KraneShares MSCI All China Health Care Index ETF (6KSF)
XBER 
ARCA Primary XBER Summary
6KSF Chart
China's Healthcare ETFs Outpace U.S. Competitors
When it comes to creating a well-diversified portfolio, healthcare stocks have traditionally offered a variety of benefits. As an innovative sector, healthcare companies offer the potential to build long-term portfolio growth.
3 ETFs Thriving in April's Market Chaos—Are You Missing Out?
With markets see-sawing up and down on a daily (or even minute-by-minute) basis on hints of global tariffs updates, there's an opportunity to time an investment to win short-term gains.
A KURE for China Tariff Concerns
An escalating trade war with China elevates a number of risk factors, but also creates pockets of overlooked opportunity for those with the appetite. Advisors and investors looking for contrarian opportunities in 2025 need look no further than China's healthcare sector and the KraneShares MSCI China All Shares Healthcare 10/40 Index ETF (KURE).
KraneShares MSCI All China Health Care Index ETF (6KSF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has KraneShares MSCI All China Health Care Index ETF ever had a stock split?
KraneShares MSCI All China Health Care Index ETF Profile
| XBER Exchange | US Country |
Overview
The fund is an investment vehicle focusing on the healthcare sector in China. It commits at least 80% of its net assets, alongside borrowings intended for investment purposes, to securities that either form part of its underlying index or possess economic characteristics akin to those present within this index. The underlying index is a market capitalization weighted index that is adjusted for free float and is designed to reflect the performance of the Chinese healthcare equity market. It operates with adherence to the 10/40 Constraint, ensuring a balanced representation of investments. As a non-diversified fund, it channels its investments into a concentrated selection of assets, providing a focused approach to sector-specific growth in the Chinese market.
Products and Services
- Investment in Healthcare Sector Instruments
The fund primarily invests in financial instruments related to the Chinese healthcare sector, including equities of companies operating within this industry. These instruments either form part of the fund's underlying index or share similar economic characteristics, aiming to mirror or exceed the index's equity market performance.
- Underlying Index Following with 10/40 Constraint Application
Its investment strategy is guided by the underlying index – a free float adjusted market capitalization weighted index that evaluates the equity performance of Chinese healthcare companies. The fund adheres to the 10/40 Constraint, which regulates investment concentration, thereby ensuring a level of diversification within its focused approach.
- Non-Diversified Fund Structure
Operating as a non-diversified fund, it has the freedom to invest a larger portion of its assets into fewer securities. This structure allows for potentially higher gains from individual investments but comes with a higher risk due to lesser diversification compared to diversified funds.
